| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 4 | +9.1 K | 26.7% | $2.64 | +$24.1 K |
| Sells | 1 | -25 K | 73.3% | $3.06 | -$76.5 K |
| Net | +3 | -15.9 K | -46.6% | -$52.4 K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| James C. Czirr | 10%+ Owner | $22.7 M | -$76.5 K | -0.34% | Apr 22, 2024 |
| Richard E. Uihlein | Director, 10%+ Owner | $17.7 M | Jan 24, 2024 | ||
| 10X Fund, L.P. | 10%+ Owner | $10.6 M | Dec 31, 2022 | ||
| Joel Lewis | President and CEO, Director | $3.15 M | +$3.39 K | +0.11% | Apr 24, 2024 |
| Kevin D. Freeman | Director | $289 K | +$13.4 K | +4.86% | Jun 20, 2024 |
| Richard A. Zordani Jr. | Director | $108 K | +$3.52 K | +3.38% | Apr 30, 2024 |
| Kary Eldred | Director | $96 K | +$3.75 K | +4.06% | Jan 24, 2024 |
| Jack W. Callicutt | Chief Financial Officer | $71.4 K | Jan 24, 2024 | ||
| Pol F. Boudes | Chief Medical Officer | $71.4 K | Jan 24, 2024 | ||
| Marc Rubin | Director | Jan 24, 2024 | |||
| Gilbert F. Amelio | Director | Jan 24, 2024 | |||
| Gilbert S. Omenn | Director | Jan 24, 2024 | |||
| Harold H. Shlevin | Director | Jan 26, 2023 | |||
| Elissa J. Schwartz | Director | Jan 24, 2024 | |||
| Benjamin Carson | Director | Jan 24, 2024 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|